Burrill health fund tops $500m with eye on exit alternatives, new markets
This article was originally published in Clinica
Executive Summary
Burrill & Company has added nearly $200m to its fourth venture capital fund, giving the life science-focused financial services firm $505m to invest in therapeutics, diagnostics, medical devices, health care services and digital health.